SUBMIT YOUR RESEARCH
Saudi Journal of Medical and Pharmaceutical Sciences (SJMPS)
Volume-3 | Issue-12 | 1322-1329
Original Research Article
Analytical Method Development and Validation of Metformin Hydrochloride and Benfotiamine in Bulk and Marketed Formulations
A. Tari, Padmavathi P. Prabhu, Paramita Das
Published : Dec. 30, 2017
DOI : 10.36348/sjmps.2017.v03i12.010
Abstract
In the present work, two simple and sensitive UV spectrophotometric methods have been developed for the quantitative estimation of Metformin Hydrochloride and Benfotiamine in combination using bulk and pharmaceutical dosage forms. Method A is Simultaneous equation method which involves measurement of absorbance at selected wavelength and solving the simultaneous equation to calculate the amount of drug present. Distilled water was used as the solvent for the analysis of both drugs. Two wavelengths 230 and 246 nm were selected for the estimation of Metformin Hydrochloride and Benfotiamine. LOD for Metformin Hydrochloride and Benfotiamine were found to be 0.03µg/ml and 0.27µg/ml respectively. Method validation was done as per ICH guidelines. Method B is Absorbance ratio method which involves, formation of Q-Absorbance equation at 239 nm (isoabsorptive point) and 246 nm (λmax of Benfotiamine) in distilled water. The Linearity lies between 2-16 µg/ml for Metformin Hydrochloride and 2-18 µg/ml for Benfotiamine with r2=0.999 and 0.998 respectively. LOD for both drugs were found to be 0.16 µg/ml and 0.3 µg/ml respectively. Method validation was done as per ICH guidelines
Scholars Middle East Publishers
Browse Journals
Payments
Publication Ethics
SUBMIT ARTICLE
Browse Journals
Payments
Publication Ethics
SUBMIT ARTICLE
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© Copyright Scholars Middle East Publisher. All Rights Reserved.